跳至主要内容
临床试验/NL-OMON33343
NL-OMON33343已完成不适用

The effects of iron loading and iron chelation during human endotoxemia. - iron loading and iron chelation during human endotoxemia.

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age >= 18 and <= 35 yrs

排除标准

  • - Use of any medication or anti-oxidant vitamin supplements
  • - History of allergic reaction to iron preparations or iron chelators.
  • - History of frequent vaso-vagal collapse
  • - History, signs or symptoms of cardiovascular disease
  • - (Family) history of myocardial infarction or stroke under the age of 65 years
  • - Cardiac conduction abnormalities on the ECG consisting of a 1st degree atrioventricular block or a complex bundle branch block.
  • - Hypertension (defined as RR systolic > 160 or RR diastolic > 90)
  • - Hypotension (defined as RR systolic < 100 or RR diastolic < 50)
  • - Renal impairment (defined as plasma creatinin >120 µmol/l)
  • - Liver enzyme abnormalities or positive hepatitis serology
  • - Subjects with elevated bilirubin levels >20 umol/l
  • - Dyslipidemia or elevated glucose level
  • - Positive HIV serology
  • - Immune deficiency
  • - Febrile illness in the week before the LPS challenge
  • - Participation in a drug trial or donation of blood 3 months prior to the LPS challenge
  • - Participation in a previous study in which LPS was administered.

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验